NFKB1 and B-cell chronic lymphocytic leukemia: Moreover, CLL cells demonstrate higher NF-κB DNA binding activity than untransformed B cells, the RelA subunit of NF-κB has been shown to be associated with clinical disease progression, and RelA binding activity is inversely correlated with apoptosis in CLL cells [7].